Compare IBRX & TTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | TTC |
|---|---|---|
| Founded | 2014 | 1914 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Tools/Hardware |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 9.3B |
| IPO Year | 2015 | 1994 |
| Metric | IBRX | TTC |
|---|---|---|
| Price | $8.08 | $98.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $12.57 | ★ $104.00 |
| AVG Volume (30 Days) | ★ 8.5M | 536.8K |
| Earning Date | 05-08-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 1.66% |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ 2.18 |
| Revenue | $113,288,000.00 | ★ $2,618,650,000.00 |
| Revenue This Year | $88.59 | $6.13 |
| Revenue Next Year | $131.15 | $4.45 |
| P/E Ratio | ★ N/A | $45.62 |
| Revenue Growth | ★ 668.31 | 4.53 |
| 52 Week Low | $1.95 | $67.64 |
| 52 Week High | $12.43 | $105.19 |
| Indicator | IBRX | TTC |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 57.38 |
| Support Level | $6.68 | $91.43 |
| Resistance Level | $8.46 | $101.31 |
| Average True Range (ATR) | 0.33 | 2.00 |
| MACD | 0.08 | 0.06 |
| Stochastic Oscillator | 53.00 | 70.51 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.